Recap: Rigel Pharmaceuticals Q1 Earnings
Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
B. Riley Securities Initiates Coverage On Rigel Pharmaceuticals with Neutral Rating, Announces Price Target of $4
B. Riley Securities analyst Kalpit Patel initiates coverage on Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral rating and announces Price Target of $4.
Looking Into Rigel Pharmaceuticals’s Return On Capital Employed
Rigel Pharmaceuticals (NASDAQ:RIGL) brought in sales totaling $20.41 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.06%, resulting in a loss of $22.64 million.
68 Biggest Movers From Yesterday
Gainers
ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday.
Recap: Rigel Pharmaceuticals Q4 Earnings
Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Rigel Pharmaceuticals’s Earnings Outlook
Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement.
Analysts estimate that Rigel Pharmaceuticals will report an earnings per share (EPS) of $-0.13.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
